A icon

Agilent Technologies

120.85 USD
+1.60
1.34%
Updated Jul 8, 10:22 AM EDT
1 day
1.34%
5 days
2.90%
1 month
3.52%
3 months
21.71%
6 months
-11.79%
Year to date
-9.43%
1 year
-4.14%
5 years
34.97%
10 years
211.87%
 

About: Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Employees: 17,900

0
Funds holding %
of 7,311 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

18% more call options, than puts

Call options by funds: $138M | Put options by funds: $116M

13% more funds holding in top 10

Funds holding in top 10: 8 [Q4 2024] → 9 (+1) [Q1 2025]

1.18% less ownership

Funds ownership: 88.29% [Q4 2024] → 87.12% (-1.18%) [Q1 2025]

6% less funds holding

Funds holding: 1,060 [Q4 2024] → 1,000 (-60) [Q1 2025]

14% less capital invested

Capital invested by funds: $33.9B [Q4 2024] → $29B (-$4.85B) [Q1 2025]

17% less repeat investments, than reductions

Existing positions increased: 329 | Existing positions reduced: 398

30% less first-time investments, than exits

New positions opened: 97 | Existing positions closed: 138

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$116
4%
downside
Avg. target
$132
9%
upside
High target
$155
28%
upside

9 analyst ratings

positive
33%
neutral
67%
negative
0%
Evercore ISI Group
Vijay Kumar
8%upside
$130
In-Line
Maintained
8 Jul 2025
Barclays
Luke Sergott
3%upside
$125
Equal-Weight
Maintained
24 Jun 2025
UBS
Elizabeth Garcia
8%upside
$130
Neutral
Maintained
29 May 2025
JP Morgan
Tycho Peterson
28%upside
$155
Overweight
Maintained
29 May 2025
Baird
Catherine Schulte
16%upside
$140
Outperform
Maintained
22 May 2025

Financial journalist opinion

Based on 3 articles about A published over the past 30 days

Neutral
Benzinga
1 week ago
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Positive
Zacks Investment Research
1 week ago
Why Is Agilent (A) Up 5.4% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock?
Why Is Agilent (A) Up 5.4% Since Last Earnings Report?
Neutral
Business Wire
3 weeks ago
Agilent to Showcase New Products and Innovations at HPLC 2025
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spectrometers at the upcoming HPLC 2025 conference in Bruges, Belgium. These new additions are designed to boost laboratory efficiency and deliver superior results. Exhibition attendees will be able to see how these products can streamline operations and enhance analytical outcomes. The Agilent Infinit.
Agilent to Showcase New Products and Innovations at HPLC 2025
Neutral
Seeking Alpha
1 month ago
Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Agilent Technologies, Inc. (NYSE:A ) Jefferies Global Healthcare Conference Call June 4, 2025 10:30 AM ET Company Participants Padraig McDonnell - CEO, President & Director Robert W. McMahon - Senior VP & CFO Conference Call Participants Tycho W.
Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Neutral
Zacks Investment Research
1 month ago
Don't Overlook Agilent (A) International Revenue Trends While Assessing the Stock
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Don't Overlook Agilent (A) International Revenue Trends While Assessing the Stock
Neutral
Zacks Investment Research
1 month ago
Agilent Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
A's second-quarter fiscal 2025 results benefit from strong LC & services, but margin contraction raises investor concerns.
Agilent Q2 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise
Neutral
Seeking Alpha
1 month ago
Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q2 2025 - Earnings Conference Call May 28, 2025 4:30 PM ET Company Participants Parmeet Ahuja – VP, IR Padraig McDonnell - President and CEO Robert W. McMahon - SVP and CFO Simon May - President of Life Sciences and Diagnostics Markets Group Angelica Riemann - President of Agilent CrossLab Group Mike Zhang - President of Applied Markets Group Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Puneet Souda - Leerink Partners Vijay Kumar - Evercore ISI Tycho Peterson - Jefferies Brandon Couillard - Wells Fargo Michael Ryskin - Bank of America Dan Leonard - UBS Operator Good afternoon.
Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript
Neutral
Zacks Investment Research
1 month ago
Here's What Key Metrics Tell Us About Agilent (A) Q2 Earnings
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended April 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Agilent (A) Q2 Earnings
Positive
Zacks Investment Research
1 month ago
Agilent Technologies (A) Q2 Earnings and Revenues Top Estimates
Agilent Technologies (A) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.22 per share a year ago.
Agilent Technologies (A) Q2 Earnings and Revenues Top Estimates
Positive
Reuters
1 month ago
Life sciences firm Agilent beats quarterly estimates on instrument demand
Agilent Technologies beat Wall Street estimates for second-quarter profit and revenue on Wednesday, helped by strong demand for its tools and equipment used in drug development, sending its shares up 5.1% in extended trading.
Life sciences firm Agilent beats quarterly estimates on instrument demand
Charts implemented using Lightweight Charts™